Virmani R - Search Results

1

Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms.

Newman AAC, Serbulea V, Baylis RA, Shankman LS, Bradley X, Alencar GF, Owsiany K, Deaton RA, Karnewar S, Shamsuzzaman S, Salamon A, Reddy MS, Guo L, Finn A, Virmani R, Cherepanova OA, Owens GK. Newman AAC, et al. Among authors: virmani r. Nat Metab. 2021 Feb;3(2):166-181. doi: 10.1038/s42255-020-00338-8. Epub 2021 Feb 22. Nat Metab. 2021. PMID: 33619382 Free PMC article.

2

Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.

Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Finn AV, et al. Among authors: virmani r. Circulation. 2005 Jul 12;112(2):270-8. doi: 10.1161/CIRCULATIONAHA.104.508937. Epub 2005 Jul 5. Circulation. 2005. PMID: 15998681

3

Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.

Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Virmani R, et al. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2054-61. doi: 10.1161/01.ATV.0000178991.71605.18. Epub 2005 Jul 21. Arterioscler Thromb Vasc Biol. 2005. PMID: 16037567 Review.

4

Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.

Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Gold HK, Virmani R. Joner M, et al. Among authors: virmani r. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):182-9. doi: 10.1161/01.ATV.0000251021.28725.e8. Epub 2006 Oct 26. Arterioscler Thromb Vasc Biol. 2007. PMID: 17068283

5

Vascular responses to drug eluting stents: importance of delayed healing.

Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Finn AV, et al. Among authors: virmani r. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10. doi: 10.1161/ATVBAHA.107.144220. Epub 2007 May 17. Arterioscler Thromb Vasc Biol. 2007. PMID: 17510464 Review.

6

Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?

Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R. Kolodgie FD, et al. Among authors: virmani r. J Am Coll Cardiol. 2007 May 29;49(21):2093-101. doi: 10.1016/j.jacc.2006.10.083. Epub 2007 May 17. J Am Coll Cardiol. 2007. PMID: 17531658 Free article. Review.

7

Vascular pathology of drug-eluting stents.

Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Among authors: virmani r. Herz. 2007 Jun;32(4):274-80. doi: 10.1007/s00059-007-2997-9. Herz. 2007. PMID: 17607533 Review.

8

Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.

Jain RK, Finn AV, Kolodgie FD, Gold HK, Virmani R. Jain RK, et al. Among authors: virmani r. Nat Clin Pract Cardiovasc Med. 2007 Sep;4(9):491-502. doi: 10.1038/ncpcardio0979. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17712362 Review.

9

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.

Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R. Nakazawa G, et al. Among authors: virmani r. Am J Cardiol. 2007 Oct 22;100(8B):36M-44M. doi: 10.1016/j.amjcard.2007.08.020. Am J Cardiol. 2007. PMID: 17950831 Review.

10

Drug-eluting stent pathology--should we still be cautious?

Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Among authors: virmani r. Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):1. doi: 10.1038/ncpcardio1093. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18094669 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,112 results

Search Page